Petros Pharmaceuticals, Inc.
PTPI
$0.0199
-$0.038-65.63%
NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -9.27M | -2.22M | -662.00K | -2.16M | 318.20K |
| Total Depreciation and Amortization | 667.30K | 768.30K | 754.70K | 753.50K | 837.20K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7.35M | -143.10K | -1.48M | -1.48M | -5.16M |
| Change in Net Operating Assets | 2.23M | 824.30K | -278.80K | 1.76M | 1.74M |
| Cash from Operations | 965.40K | -771.20K | -1.66M | -1.13M | -2.26M |
| Capital Expenditure | -5.40K | -19.10K | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -5.40K | -19.10K | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00 | -385.50K | -379.80K | -- | -374.20K |
| Issuance of Common Stock | -- | -- | -- | -- | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -1.14M | -2.39M | -1.58M | -1.12M | -2.00M |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -1.14M | -2.77M | -1.96M | -1.12M | -2.37M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -184.70K | -3.57M | -3.62M | -2.26M | -4.63M |